Lucent BioSciences
PrivateLast Round
Grant
Nov 7, 2023
Total Funding Raised
$7.89M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Lucent BioSciences operates in Energy & Sustainability and is based in West Vancouver, British Columbia. Its latest recorded funding round was a Grant round in November 2023.
Lucent BioSciences is an agritech company that develops sustainable, non-polluting crop nutrition products from upcycled plant-based materials.
Sector
Energy & Sustainability
Verticals
Circular Economy, Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lucent BioSciences Comparables
Compare Lucent BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sound | 78% | |
| Verdesian Life Sciences | 78% | |
| Prospect Growth | 77% |
For institutional investors. Book with your work email.
Lucent BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 7, 2023 | ||||
| Grant | Mar 15, 2023 | ||||
| Seed | Nov 23, 2021 | ||||
| Grant | Mar 31, 2021 | ||||
| Grant | Mar 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lucent BioSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SVG Ventures|THRIVE | Seed |
| Amathaon Capital | Seed |
| Pacific Economic Development Canada | Grant |
| WUTIF Management Corporation | Seed |
| Protein Industries Canada | Grant |
| Government of Canada | Grant |
| Women's Equity Lab | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 63, 4.6x the trailing average.
- Jul 20, 2026
Open roles increased to 63, 233% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 17, 2026
Lucent BioSciences, Inc. receives up to $1.98M under the Agricultural Clean Technology Program’s Research and Innovation Stream on Sep 16th '26 in Canada to develop sustainable fertilizer technology.
- partners_withSep 16, 2026
In a project applying biodegradable biopolymer technology to controlled-release nitrogen, Lucent BioSciences, Inc. is also partnering with A&L Canada Laboratories Inc..
- partners_withSep 16, 2026
Lucent BioSciences, Inc. partnered with 4d Labs on Jul 1st '22.
- partners_withSep 16, 2026
As part of a project applying biodegradable biopolymer technology to controlled-release nitrogen, Lucent BioSciences, Inc. is partnering with Bureau Veritas.
- partners_withSep 16, 2026
Lucent BioSciences, Inc. is partnering with SFU group on a project applying biodegradable biopolymer technology to controlled-release nitrogen.
For institutional investors. Book with your work email.
Lucent BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lucent BioSciences's valuation, stock price, and market status.
Is Lucent BioSciences a public or private company?
Lucent BioSciences is a private company.
What is the current stock price of Lucent BioSciences?
Lucent BioSciences is a private company, so its shares have no public market price. Caplight tracks Lucent BioSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lucent BioSciences worth (valuation)?
Valuation information for Lucent BioSciences is not publicly available.
Can I buy Lucent BioSciences stock?
Lucent BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lucent BioSciences's last funding round?
Lucent BioSciences's most recent funding round was Grant on November 7, 2023.
Who are the main investors in Lucent BioSciences?
Key investors in Lucent BioSciences include Pacific Economic Development Canada, Protein Industries Canada, Government of Canada, Conexus Venture Capital, Innovate BC.
Will Lucent BioSciences IPO soon?
No public IPO plans have been announced for Lucent BioSciences.
How can I track Lucent BioSciences secondary market activity?
Caplight tracks bids, offers, and trades in Lucent BioSciences's shares on secondary markets.